MedTrace Logo

Iron Supplementation of Lead-exposed Infants

NCT00374790 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-05-15

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of iron (12.5 mg as ferrous sulfate) and placebo given for 6 months in preventing the elevation of blood lead concentration in children 6-9 months of age.

Conditions

  • Lead Toxicity

Interventions

DRUG

Ferrous sulfate

Sponsors & Collaborators

Principal Investigators

  • Katarzyna Kordas, PhD · Cornell University

  • Rebecca J Stoltzfus, PhD · Cornell University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-05-31
Completion
2008-07-31

Countries

  • Uruguay

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00374790 on ClinicalTrials.gov